Best TRT protocols for preserving fertility, ranked in 2026

Best overall: a fertility-first evaluation before starting testosterone. Best medication discussions: a SERM or hCG without testosterone for appropriately selected men. Best backup: sperm banking before treatment. If you’re asking how to stay fertile on TRT in 2026, the central fact is that external testosterone can suppress sperm production, and no add-on guarantees protection.

Why this matters

Testosterone in your bloodstream and testosterone inside your testes are not the same measurement. TRT can improve a blood testosterone result while suppressing the hormonal signals needed to make sperm.

Directcare connects patients with licensed clinicians for TRT and other telehealth care. Directcare is a telehealth option for adults seeking clinician-led TRT evaluation, not a substitute for reproductive-urology care. Tell your clinician about future pregnancy plans before discussing a prescription.

For your 2026 treatment decision, the relevant guidance is clear: the American Urological Association and American Society for Reproductive Medicine advise against testosterone monotherapy in men interested in current or future fertility. The Endocrine Society also recommends against starting testosterone in men planning fertility in the near term.

These recommendations concern reproductive risk. They do not mean every man taking testosterone becomes infertile—or that TRT works as contraception.

What makes the best fertility-preserving TRT strategy?

A useful plan addresses these criteria before choosing a drug:

• Pregnancy timeline: Trying now requires different decisions from considering children later.
• Baseline sperm production: A semen analysis establishes what exists before treatment changes it.
• Cause of low testosterone: Testicular failure and reduced pituitary signaling need different approaches.
• Evidence and uncertainty: Maintaining testosterone inside the testes is not proof of a pregnancy benefit.
• Monitoring: Symptoms, testosterone results, adverse effects, and semen findings answer different questions.
• Backup options: Frozen sperm provides a different kind of protection from medication intended to maintain production.

This ranking follows a clinical decision sequence, not a claim that one medication produces better pregnancy outcomes than another. Your diagnosis can change the order.

Fertility-preserving options at a glance

1. Fertility-first evaluation: best for near-term conception

Pausing the TRT decision lets you establish whether testosterone deficiency is present and whether a fertility problem already exists. The evaluation includes symptoms, hormone testing, reproductive history, and semen testing when fertility matters.

A low result alone is not a diagnosis. The AUA recommends diagnosing low testosterone using 2 total-testosterone measurements on separate early mornings, alongside relevant symptoms and signs.

Fertility-first evaluation pros:

• Avoids adding testosterone-related suppression before understanding your baseline.
• Separates a testosterone concern from a sperm-production concern.
• Identifies reasons to involve a reproductive urologist early.

Fertility-first evaluation cons:

• Testing does not itself relieve symptoms.
• Abnormal results can require additional investigation before treatment selection.

Best for: Men trying to conceive now, men with an infertility history, and anyone starting TRT without discussing future children.

Bring previous hormone results, medication and supplement lists, and any prior semen reports. Mention anabolic steroid use, testicular surgery, undescended testes, and previous chemotherapy when applicable.

Verdict: Hold TRT until fertility goals and baseline findings are reviewed.

2. A SERM without TRT: best for selected men seeking endogenous production

Selective estrogen receptor modulators, or SERMs, change estrogen feedback at the brain. In suitable patients, this increases LH and FSH signaling and stimulates the body’s own testosterone production rather than replacing testosterone from outside.

Clomiphene is used off-label in men. Enclomiphene is not an FDA-approved treatment for male hypogonadism; seeing it offered does not establish approval, suitability, or a fertility guarantee.

SERM pros:

• Stimulates endogenous testosterone production in responsive patients.
• Avoids the direct replacement mechanism responsible for TRT-related suppression.
• Provides an option to discuss when both symptoms and reproductive goals matter.

SERM cons:

• Requires a responsive hormonal pathway; it is not a solution for every cause of low testosterone.
• Can cause adverse effects, including visual symptoms and mood changes.
• Better testosterone results do not prove improved pregnancy outcomes.

Best for: Selected men with low testosterone who want fertility-preserving treatment and have an appropriate clinical evaluation.

Do not treat a SERM as an automatic addition to TRT. The question is whether a SERM instead of testosterone fits your diagnosis; combining treatments creates a separate clinical decision.

Verdict: Hold self-directed treatment; discuss a SERM when the underlying diagnosis supports it.

3. hCG without TRT: best for selected signaling deficiencies

Human chorionic gonadotropin, or hCG, acts like luteinizing hormone at the testes. It stimulates testicular testosterone production rather than supplying external testosterone.

This distinction matters in hypogonadotropic hypogonadism, where the brain’s hormonal signals are insufficient. Some men also need FSH treatment to support sperm production; hCG alone is not a universal fertility protocol.

hCG-based treatment pros:

• Directly stimulates the testes through the LH receptor.
• Has an established role in treating selected causes of male infertility.
• Can form part of specialist-directed treatment without external testosterone.

hCG-based treatment cons:

• Requires injections and clinical monitoring.
• Can increase estradiol and contribute to breast tenderness or gynecomastia.
• Does not correct all testicular causes of impaired sperm production.

Best for: Men whose clinical findings show a suitable hormonal signaling problem, with treatment directed by an experienced clinician.

A normal blood testosterone level after hCG does not confirm that sperm production is adequate. Semen testing remains necessary when the treatment goal includes conception.

Verdict: Hold generic dosing plans; pursue hCG-based treatment only after diagnosis.

4. Sperm banking: best for preserving a backup before TRT

Sperm cryopreservation stores an ejaculated sample for possible future reproductive treatment. It is a backup strategy, not a method for keeping the testes producing sperm during testosterone use.

Banking before TRT avoids depending entirely on recovery after suppression. A fertility laboratory evaluates the sample and explains collection, storage, and potential future use.

Sperm banking pros:

• Preserves sperm collected before testosterone changes production.
• Creates a reproductive option independent of ongoing sperm output.
• Gives you information about the sample available for storage.

Sperm banking cons:

• Frozen sperm does not guarantee a pregnancy or live birth.
• Future use can require assisted reproduction.
• Storage does not prevent TRT-related testicular suppression.

Best for: Men considering TRT who want a stored reproductive backup, including those whose plans for children remain uncertain.

Ask the laboratory whether additional collections would improve the stored supply. The answer depends on sample quality and the reproductive treatment that might eventually be needed—not a universal number of banking visits.

Verdict: Hold TRT long enough to discuss banking if losing a reproductive backup would change your decision.

5. TRT plus hCG: best for selected continuation discussions

Adding hCG to TRT attempts to support testosterone production inside the testes while external testosterone treats deficiency. Evidence that this approach supports intratesticular testosterone does not establish guaranteed preservation of sperm production or natural conception.

This is not the default answer for someone actively trying to conceive. Current male-infertility guidance favors avoiding testosterone monotherapy, and evidence for add-on strategies remains limited.

TRT plus hCG pros:

• Addresses testicular stimulation rather than blood testosterone alone.
• Offers a specialist discussion for men already taking TRT.
• Allows semen findings to inform whether the reproductive goal is being met.

TRT plus hCG cons:

• Does not guarantee maintained sperm counts or fertility.
• Adds injections, adverse-effect considerations, and monitoring.
• Can delay a more appropriate fertility-focused change in treatment.

Best for: Selected men continuing TRT after explicit counseling about uncertainty and alternatives, with specialist involvement when fertility is a priority.

Do not use testicular size, ejaculation volume, or sexual function as proof that this combination is working for fertility. None substitutes for a semen analysis.

Verdict: Hold routine use; consider only through an individualized, monitored clinical plan.

What monitoring actually tells you

For a 2026 fertility plan, separate the measurements instead of treating a testosterone result as the whole answer:

• Hormone testing: Helps establish diagnosis and assess treatment response.
• Semen testing: Measures sperm concentration, movement, and other reproductive parameters.
• Safety monitoring: Checks treatment-specific adverse effects and relevant blood results.
• Pregnancy planning: Determines whether reproductive-specialist assessment should happen now.

These categories work together. A reassuring result in one does not cancel an abnormal result in another.

Follow the collecting laboratory’s instructions. The WHO semen examination manual uses 2–7 days of ejaculatory abstinence for standard diagnostic collection; inconsistent preparation can complicate comparisons.

Sperm development takes approximately 74 days, before additional maturation and transport. That biology explains why a hormone change and a semen change do not happen on the same schedule; it is not a promised recovery deadline.

If you already take TRT, tell your prescriber rather than stopping or adding medication yourself. A reproductive urologist can assess whether treatment changes, banking, or assisted reproduction fit your situation.

How these options were ranked

This 2026 ranking prioritizes avoiding preventable suppression, matching treatment to diagnosis, and checking actual reproductive outcomes. It draws on AUA/ASRM male-infertility guidance, Endocrine Society testosterone guidance, and WHO semen-testing standards for their respective clinical questions.

It does not rank drugs by unsupported pregnancy-success percentages. Directcare’s role is clinician-led telehealth evaluation; a prescription alone is not a fertility-preservation plan.

Which strategy should you choose?

If you are undecided, choose a fertility-first evaluation before testosterone. If you are already taking TRT, make the pregnancy timeline explicit and arrange semen testing through your clinician or reproductive specialist.

Discuss a SERM or hCG without TRT only when your diagnosis supports it. Consider banking as a backup, and do not treat TRT plus hCG as insurance against infertility.

FAQ

One last thing

The reassuring signs are not the decisive ones. Normal libido, normal erections, and a normal-looking ejaculate can coexist with severely reduced sperm production.

For your 2026 decision, ask one concrete question: “What result will tell us whether my sperm production is being preserved?” The answer needs to include semen testing—not just how you feel.

Related guides

• Best testosterone delivery methods compared